On the other hand, a strong intensity of the signal (score 3) is associated with HER2+ breast cancer (Figure 3C, third lane) and with the positive control, i.e., IHC of anti KCTD15 antibody (Spleen tissue, Supplementary Figure S4). Here, ERBB2 is linked to breast carcinoma.